According to the UnivDatos, the rise of cancer cases, increasing incidence of HIV, expansion of combination therapies, and increasing focus towards AI application in the drug discovery drive the CXCR4 antagonist market. As per their “CXCR4 Antagonist Market” report, the global Market was valued at USD 507.04 million in 2023, growing at a CAGR of about 12.37% during the forecast...